
Personal Chair
- About
-
Biography
Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.
- Publications
-
Page 4 of 9 Results 31 to 40 of 81
Lanadelumab for preventing recurrent attacks of hereditary angioedema.
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsLorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer
Commissioned by National Institute for Health and Care Excellence. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsRisankizumab for treating moderate to severe plaque psoriasis
Evidence Review Group report in support of NICE Fast Track Appraisal Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsTYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices.
National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsThe ARCHITECT and Alinity urine NGAL assays, urine NephroCheck test, and urine and plasma NGAL tests to help assess the risk of acute kidney injury in people who are being considered for admission to critical care
National Institute for Health and Care Excellence (NICE). 376 pagesBooks and Reports: Commissioned ReportsDupilumab for treating adults with moderate to severe atopic dermatitis.
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsMultiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation
Health Technology Assessment, vol. 22, no. 1, pp. 1-138Contributions to Journals: Literature Reviews- [ONLINE] DOI: https://doi.org/10.3310/hta22010
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/10101/1/3011920.pdf
HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial
Trials, vol. 19, 63Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/s13063-017-2374-9
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/10005/1/HEALTH_laparoscopic_supracervical_hysterectomy_versus_second_generation_endometrial_ablation_for_the_treatment_of_heavy_menstrual_bleeding_study_protocol_for_a_randomised_controlled_trial.pdf
Teduglutide for treating short bowel syndrome
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 142 pagesBooks and Reports: Commissioned ReportsA pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol
BMJ Open, vol. 7, e017134Contributions to Journals: Articles